CrushSCI.com
57.8平均天数
49中位天数
1最短天数
196最长天数
222025发文量

Paper Review Records

全部论文审稿周期

12 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

80 天

Thrombotic and Hemorrhagic Events in Myeloproliferative Neoplasms

作者
Kari Brown; Douglas Tremblay展开收起
作者单位
1. Hematology/Oncology Section, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA展开收起
PDF源文件 DOI 网页
196 天

Approach to Patients with Multiple Myeloma after BCMA targeted Therapy

作者
Hanne Marie Norseth; Rakesh Popat; Fredrik Schjesvold展开收起
作者单位
1. Oslo University Hospital; 2. University of Oslo; 3. University College London Hospitals NHS Foundation Trust展开收起
PDF源文件 DOI 网页
49 天

Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development

作者
Kateryna Fedorov; Leo Y. Luo; Alexander G. Bick; Michael R. Savona展开收起
作者单位
1. Vanderbilt-Ingram Cancer Center, Nashville, US; 2. Division of Hematology and Oncology, Department of Medicine, Nashville, US; 3. Vanderbilt School of Medicine, Vanderbilt University Medical Center, Nashville, US; 4. Department of Radiation Oncology, Nashville, US; 5. Division of Genetic Medicine, Department of Medicine, Nashville, US展开收起
PDF源文件 DOI 网页
48 天

Targeting RUNX1 Germline Variants: Agents Under Investigation

作者
Saman Ghalamkari; Christopher N. Hahn; Amelia Lau; Hamish S. Scott; Claire C. Homan; Anna L. Brown展开收起
作者单位
1. Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia; 2. Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia; 3. Adelaide Medical School, The University of Adelaide, Adelaide, Australia展开收起
PDF源文件 DOI 网页
1 天

The Evolving Therapeutic Landscape of Richter Transformation

作者
Henry Le; Grace Baek; Ivan Huang; Chloe Siu; Mazyar Shadman展开收起
作者单位
1. Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, USA; 2. Department of Pharmacy, University of Washington Medical Center, Seattle, United States; 3. Department of Cellular Immunotherapy, Fred Hutchinson Cancer Center, Seattle, USA; 4. Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, USA展开收起
PDF源文件 DOI 网页
17 天

Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy

作者
Tala Najdi; Sarah Khanfour; Joe Chalhoub; Shereen Sakkal; Fadi G. Haddad; Hampig Raphael Kourie展开收起
作者单位
1. Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon; 2. Saint Joseph University of Beirut, Beirut, Lebanon; 3. Faculty of Medicine, University of Montreal, Quebec, Canada; 4. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA展开收起
PDF源文件 DOI 网页

FAQ

Current Hematologic Malignancy Reports审稿要多久?

截至2026-11-19,CrushSCI 收录了 Current Hematologic Malignancy Reports 的 12 篇完整审稿记录。最快一篇从收稿到录用用了 1 天(The Evolving Therapeutic Landscape of Richter Transformation,2025-11-02 收稿,2025-11-03 录用),最慢一篇用了 196 天;平均 57.8 天,中位数 49 天。最快这篇的日期间隔异常短,建议点开原文核对。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。